Endometrial Effects of Daily Progesterone s.c. 25 and 50 Mg Aqueous Formulation to Female Healthy Volunteers
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
This is a multiple dose, observer blind, randomised, parallel groups pharmacodynamic and
pharmacokinetic study to assess the endometrial effects (predecidual changes) of a new
aqueous progesterone formulation administered s.c. at the dose of 25 and 50 mg/day.